People: Endo International PLC (ENDP.OQ)

ENDP.OQ on NASDAQ Stock Exchange Global Select Market

1:30am IST
Change (% chg)

$-0.10 (-2.38%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Cooke, Shane 

Mr. Shane M. Cooke is an Independent Director of Endo International Public Limited Company. He has been a member of the Board of Directors since July 2014 and is Chair of Endo’s Audit Committee. In March 2018, Mr. Cooke retired from Alkermes plc (Alkermes), most recently having served as its President since 2011, when Elan Drug Technologies (EDT) merged with Alkermes. Mr. Cooke was appointed to the board of directors of Alkermes in March 2018. From 2007 until 2011, he was head of EDT and Executive Vice President of Elan and concurrently served as Chief Financial Officer of Elan Corporation from 2001 to 2011. Mr. Cooke was appointed director of Elan in 2005. Prior to joining Elan, he was Chief Executive of Pembroke Capital Limited, an aviation leasing company of which he was a founder. Mr. Cooke also previously held a number of senior positions in finance in the banking and aviation industries. He currently serves on the boards of directors of Alkermes, Prothena Corporation plc, a publicly traded biotechnology company, and UDG Healthcare plc, a publicly traded company providing healthcare advisory, communications, commercial, clinical and packaging services through its two divisions: Ashfield and Sharp. Mr. Cooke is a chartered accountant and a graduate of University College Dublin, Ireland.

Basic Compensation

Total Annual Compensation, USD 85,000
Restricted Stock Award, USD 240,000
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 325,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --